Getting a prostate cancer diagnosis isn't a death sentence. Still, it's important to know about its different stages, so that ...

Metastatic castration-resistant prostate cancer (mCRPC) is diagnosed by blood tests, imaging scans, and biopsies. Find out ...

Mohammad Mahmoud, MD, MS, reviews important updates in metastatic prostate cancer presented at AUA 2025, including promising ...

Decipher Prostate Metastatic Genomic Classifier is now available for patients with metastatic prostate cancer.

Two phase 3 trials of Merck & Co's Keytruda in metastatic castration-resistant prostate cancer (CRPC) and advanced liver cancer have ended in failure, proving once again that cancer immunotherapy ...

At the American Urological Association annual meeting, several studies explored the potential role of surgery in managing ...

The treatment of metastatic castration-resistant prostate cancer (mCRPC ... as well as the bladder, rectum, liver, lungs, and possibly the brain. With mCRPC, androgen deprivation therapy (ADT ...

Many men with metastatic hormone-sensitive prostate cancer have not received recommended first-line therapies due to clinicians’ unfamiliarity with treatment guidelines and misinformation about ...

Brain metastases from prostate cancer (PC) seem to be more frequent than in the past, possibly because advances in the treatment of patients with castration-resistant PC have prolonged their survival.

SIRT with 90Y resin microspheres led to durable disease control in patients with gastrointestinal stromal tumor liver ...

"More than 70% of Asian prostate cancer patients are in the intermediate or advanced stage at the first diagnosis. They are more prone to metastasis and drug resistance, which is consistent with a ...